研究论文

木犀草素-7-O-葡萄糖苷与双链DNA的相互作用研究

  • 马蕾 ,
  • 刘舒 ,
  • 宋凤瑞 ,
  • 刘志强 ,
  • 刘淑莹
展开
  • a 中国科学院长春应用化学研究所长春质谱中心 长春 130022;
    b 中国科学院研究生院 北京 100039

收稿日期: 2012-03-30

  网络出版日期: 2012-05-17

基金资助

项目受国家自然科学基金(Nos. 21073178, 21175128)资助.

Studies on the Interaction between Luteolin-7-O-glucoside and Duplex DNA

  • Ma Lei ,
  • Liu Shu ,
  • Song Fengrui ,
  • Liu Zhiqiang ,
  • Liu Shuying
Expand
  • a Changchun Center of Mass Spectrometry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022;
    b Graduate School of the Chinese Academy of Sciences, Beijing 100039

Received date: 2012-03-30

  Online published: 2012-05-17

Supported by

Project supported by the National Natural Science Foundation of China (Nos. 21073178, 21175128).

摘要

采用电喷雾质谱(ESI-MS)、紫外吸收光谱(UV)以及荧光光谱结合溴化乙锭荧光探针研究黄酮类化合物木犀草 素-7-O-葡萄糖苷与双链DNA的相互作用. 质谱研究结果表明木犀草素-7-O-葡萄糖苷可与双链DNA形成复合物, 且Lug与DNA之间存在氢键作用, 通过串联质谱数据推断出其结合模式为插入型. 紫外吸收光谱研究结果表明DNA的加入使木犀草素-7-O-葡萄糖苷产生明显的减色红移效应, 说明该化合物可能插入DNA双螺旋碱基对间. 荧光光谱研究结果表明木犀草素-7-O-葡萄糖苷能引起溴化乙锭-DNA体系荧光强度明显减弱和波长轻微蓝移, 主要是单一的静态猝灭, 猝灭常数Kq=8.61×1011 L·mol-1·s-1, 进一步说明Lug与DNA的主要作用方式为插入型.

本文引用格式

马蕾 , 刘舒 , 宋凤瑞 , 刘志强 , 刘淑莹 . 木犀草素-7-O-葡萄糖苷与双链DNA的相互作用研究[J]. 化学学报, 2012 , 70(14) : 1561 -1564 . DOI: 10.6023/A12030072

Abstract

The interaction between luteolin-7-O-glucoside and duplex DNA was investigated by ESI-MS, ultraviolet and fluorescence spectroscopy in conjunction with fluorescent probe ethidium bromide (EB). We synthetized a critical sequence of GC-rich human survivin promoter DNA for ESI-MS investigation. The stock solutions of DNA and the drug for MS analysis were diluted with methanol/20 mmol/L ammonium acetate (20:80, V/V) solvent, giving a final concentration of DNA of 5 and 20 μmol/L for luteolin-7-O-glucoside. In negative ion mode, we found the duplex DNA/drug complex as well as complex of single-strand oligodeoxynucleotide/luteolin-7-O-glucoside in ESI-MS spectrum. At the same time, it can be seen that the flavonoid shows 1:1, 1:2 and 1:3 binding stoichiometries. In positive ion mode, only 1:1 complex was observed from the spectrum. This suggests that the complex between the drug and the duplex has hydrogen bond interaction. The spectra of tandem mass spectrometry reveal that the 5- charged 1:1 complex underwent the predominant loss G base and a little of losing a neutral drug. Moreover, for 6- charged 1:1 complex of duplex and luteolin-7-O-glucoside, its fragmentation pathway is loss of a 1-charged drug yielding a 5- charged DNA ion. The results of MS/MS data demonstrate that luteolin-7-O-glucoside is an intercalator. UV data were measured by addition of ct-DNA (80 μmol/L) to Lug (20 μmol/L)-20 mmol/L ammonium acetate solution. The result shows obvious hypochromic and red shift effect, indicating that the compound may be inserted between the pairs of the DNA helix bases. The fluorescence experiments were obtained by the drug (final concentrations: 0—66.66 μmol/L) titrating certain EB-DNA system (c(EB)=3 μmol/L, c(ct-DNA)=9.78 μmol/L) in 20 mmol/L ammonium acetate solvent. The emission spectra were recorded at an excitation wavelength of 520 nm. The results show that luteolin-7-O-glucoside can quench the fluorescence of EB-DNA system, and the wavelength of EB-DNA hypsochromic shift. The quenching of luteolin-7-O-glucoside on the fluorescence of EB-DNA is a static quenching process, quenching constant Kq=8.61×1011 L·mol-1·s-1. This reveals that luteolin-7-O-glucoside has only one mode to interact with duplex DNA. Based on the above mentioned experimental results, we can conclude that luteolin-7-O-glucoside is an intercalator. These results are expected to provide a basis to understand the DNA-binding properties of flavonoids and useful information for development of new efficient duplex DNA ligands.

参考文献

[1] Kelly, E. H.; Anthony, R. T.; Dennis, J. B. J. Nutr. Biochem. 2002, 13, 572.
[2] Vitorino, J.; Sottomayor, M. J. J. Mol. Struct. 2010, 975, 292.
[3] Hu, C.; Kitts, D. D. J. Agric. Food Chem. 2003, 52, 301.
[4] Hu, C.; Kitts, D. D. Mol. Cell. Biochem. 2004, 265, 107.
[5] Spencer, J. P. E.; Chowrimootoo, G.; Choudhury, R.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C. FEBS Lett. 1999, 485, 224.
[6] Baskar, A. A.; Ignacimuthu, S.; Michael, G. P.; AlNumair, K. S. Nutr. Cancer 2011, 63, 130.
[7] Zhang, Q.; Feng, W.-J.; Li, X.-D. J. Pharmaceut. Univ. 2010, 41, 555. (张强, 冯文军, 李晓冬, 中国医科大学学报, 2010, 41, 555.)
[8] Mello, L. D.; Pereira, R. M. S.; Sawaya, A. C. H. F.; Eberlin, M. N.; Kubota, L. T. J. Pharm. Biomed. Anal. 2007, 45, 706.
[9] Wang, L.-F.; Song, Y.-M.; Feng, Y.-F.; Zhang, Q.; Wang, Y.-Y. Acta Chim. Sinica 2004, 62, 2277. (王流芳, 宋玉民, 冯亚非, 张歧, 王印月, 化学学报, 2004, 62, 2277.)
[10] Wang, Z. F.; Cui, M.; Song, F. R.; Lu, L.; Liu, Z. Q.; Liu, S. Y. J. Am. Soc. Mass Spectrom. 2008, 19, 914.
[11] Nafisi, S.; Hashemi, M.; Rajabi, M.; Tajmir-Riahi, H. A. DNA Cell Biol. 2008, 27, 433.
[12] Qu, L.-B.; Zhao, J.-H.; Li, J.-J.; Yang, R. J. Instrument. Anal. 2008, 27, 79. (屈凌波, 赵俊宏, 李建军, 杨冉, 分析测试学报, 2008, 27, 79.)
[13] Wan, C. H.; Cui, M.; Song, F. R.; Liu, Z. Q.; Liu, S. Y. Int. J. Mass Spectrom. 2009, 283, 48.
[14] Li, H.-H.; Han, D.-W.; Yuan, G. Acta Chim. Sinica 2007, 65, 1543. (李卉卉, 韩德伟, 袁谷, 化学学报, 2007, 65, 1543.)
[15] Zhao, L.; Wu, B.-Y.; Gao, L.-H.; Wang, K.-Z. Acta Chim. Sinica 2006, 64, 1402. (赵琳, 吴宝燕, 高丽华, 王科志, 化学学报, 2006, 64, 1402.)
[16] Wang, Z. F.; Guo, X. H.; Liu, Z. Q.; Cui, M.; Song, F. R.; Liu, S. Y. J. Mass Spectrom. 2008, 43, 327.
[17] Keller, K. M.; Zhang, J. M.; Oehlers, L.; Brodbelt, J. S. J. Mass Spectrom. 2005, 40, 1362.
[18] Long, E. C.; Barton, J. K. Acc. Chem. Res. 1990, 23, 271.
[19] Animesh, P.; Sandipan, S.; Titas, M.; Ennio, Z.; Pabitra, C. Polyhedron 2011, 30, 2783.
文章导航

/